EBV Clinical Trial - Cellular Immunotherapy Treatment Antigen-Directed for

Updated 06/21/2024

Status Terminated

Clinical Trial Summary

To investigate the efficacy of autologous EBV-specific T-cells for the treatment of patients with aggressive EBV positive extranodal NK/T-cell lymphoma

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01948180
Study type	Interventional
Source	Cell Medica Ltd
Contact
Status	Terminated
Phase	Phase 2
Start date	September 2014
Completion date	September 7, 2018

See also
	Status	Clinical Trial	Phase
	Not yet recruiting	`NCT02878278` - Differences Between Chidamide Taken Daily and Twice a Week in Therapeutic Effect，Pharmacokinetics, Pharmacodynamics and EB Virus Activation	Phase 2
	Completed	`NCT01923766` - Cytotoxic T Cells to Prevent Virus Infections	Phase 1
	Terminated	`NCT03699904` - Epstein-Barr Virus Suppression in Chronic Obstructive Pulmonary Disease (EViSCO): a Phase 2 Randomised Control Trial	Phase 2
	Recruiting	`NCT01011712` - The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
	Active, not recruiting	`NCT04645147` - Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection	Phase 1
	Completed	`NCT02213068` - Belatacept 3 Month Post Transplant Conversion Study	Phase 4
	Terminated	`NCT02080416` - Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors	Phase 0
	Recruiting	`NCT02779439` - Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation	Phase 1
	Not yet recruiting	`NCT05677178` - Response Prediction in EBV-HLH Using Metabonomics Analysis
	Completed	`NCT03650231` - Comparison of Technics for Determination of Epstein-Barr Virus Serological Diagnosis
	Active, not recruiting	`NCT01945814` - Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL)	Phase 1
	Recruiting	`NCT02007356` - A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®	Phase 2
	Completed	`NCT03755440` - PD-1 Antibody in EBV Positive Metastatic Gastric Cancer Patients.	Phase 2
	Completed	`NCT03973723` - Plasma EBV DNA Monitoring in Post-treatment NPC Patients
	Completed	`NCT02318030` - CNTRP POSITIVE Study